Bullish case on RKLZ despite near-term headwinds including $3B dilution, Neutron development costs, and insider selling, citing competitive positioning as only public SpaceX competitor and substantial backlog potential. Key risks include unsustainable cash burn, insufficient revenue, and insider selling activity.